drugset / Trial / NCT02252783
BFPET for Regional Myocardial Perfusion Imaging
NaSingle-groupOpen-labelDiagnostic
Summary
BFPET will be evaluated as a diagnostic PET agent for assessing myocardial perfusion in subjects with known or suspected coronary artery disease (CAD) as compared to standard nuclear myocardial perfusion imaging (MPI). The safety of BFPET will be evaluated in known or suspected CAD subjects.
Timeline
- Start
- 2018-10-01
- Primary completion
- 2019-05-30
- Completion
- 2019-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BFPET | Diagnostic / imaging agent | 74 mbq | Intravenous |
| Subject | BFPET | Diagnostic / imaging agent | 296 mbq | Intravenous |